LUOHE CITY, China, June 15, 2021 – (ACN Newswire) – Cofttek Holding Small, a Chinese pharmaceutical manufacturer, will mass-fabricate and present the latest Urolithin A & B product to dietary complement corporations from June 2021. With 5 years of learn into ellagitannins, the source of urolithins, Cofttek is the most easy pharmaceutical facility in the sector in a disclose to mass-fabricate Urolithin A & B.
 |
| Following 5 years of learn, Cofttek has change into the most easy facility in the sector in a disclose to mass-fabricate Urolithin A & B. (Cofttek.com) |
Urolithin A possesses anti-inflammatory, anti-oxidant, anti-most cancers, hypoglycemic and other biological properties. Urolithin A can present a eradicate to the standard and hang of mitochondria, and expand the strength and persistence of rising old muscular tissues. Urolithin B has anti-inflammatory and antioxidant properties and is furthermore a regulator of skeletal muscular tissues.
Overview hang shown Urolithin A & B in aggregate might maybe maybe also be feeble in treating intervertebral disc degeneration (IDD), Alzheimer’s and dementia-linked concerns, and other ailments. After 5 years of technical learn, Cofttek’s manufacturing skill of Urolithin A & B now exceeds 2000 kg/month – the most easy biochemical firm worldwide to hang achieved mass manufacturing.
About Urolithin
Urolithins are secondary metabolites of ellagic acid derived from ellagitannins. Ellagitannins are converted by the human gut microflora into ellagic acid which is extra reworked into urolithins A, urolithin B, urolithin C and urolithin D in the astronomical intestines. Know more at https://www.cofttek.com/products/urolithin/
About Cofttek
Cofttek Holding Small, based in 2008, is a excessive-tech pharmaceutical biochemical project, integrating manufacturing, R&D and gross sales. It is situated in Luohe Chemical Exchange Park, Luohe Metropolis, Henan Province, and is committed to the learn and trend of advanced pharmaceuticals, offering innovative products and excessive-quality companies and products for the pharmaceutical industry.
Media Contact:
Dr. Zeng, Cofttek Holding Small
E: [email protected], T: +86 1390 2465871
Online page: https://www.cofttek.com
SOURCE: Cofttek Holding Small
Matter: Press originate summary
Source: Cofttek Holding Small
Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Company News Network
Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Company News Network.
